Souhaitez-vous accéder aux communiqués récents ?

Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide TherapyTM (PRnT) solutions, today announced the submission of its Investigational...

Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market...

CoreMap, Inc. Receives U.S. FDA Investigational Device Exemption (IDE) Approval for INvENI Map-Guided AF Ablation Study

BRUSSELS, March 13, 2025 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced two major advancements in AI-powered open source...

SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II...

BRUSSELS, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced the creation of the Eclipse Open Collaboration Tools...

BRUSSELS, Belgium, June 27, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source foundations, has announced the release of Eclipse Theia IDE, marking a significant...

Hyderabad, Aug. 03, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Agricultural Wastewater Treatment Market Report (2023-2028)," the market is estimated at USD 2.40...

SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...

SAN FRANCISCO, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Gitpod, the leading open source platform for automated dev environments, today announced that they have created a new open source project (licensed...